Areas of Therapedic Focus
Oncology
- Renal Disease
- Bone and Joint Disease
- Immunology/Infectious Disease
- Others
Key Historical Dates
1925--Founding of Chugai Pharmaceutical Co., Ltd.
1968--Ulcerlmin® (sucralfate) launched
1975--Picibanil® launched
1984--Sigmart® (nicorandil) launched
1990--Epogin® (epoetin beta) launched in Japan
1991--Neutrogin (lenograstim) launched in Japan
1994--Chugai Pharma Europe Ltd., established
1994--Granocyte (lenograstim) launched in Europe
1995--Chugai Biopharmaceuticals (current Chugai Pharma USA, LLC) established in San Diego, CA
2002--Strategic alliance of Roche and Chugai
2005--CPUSA moves to new headquarters in Bedminster NJ
2005--Actemra® (tocilizumab) launched in Japan
2008--CPUSA moves to new headquarters in Berkeley Heights NJ
2009--RoActemra® (tocilizumab) launched in Europe
